All-trans-retinoic Acid Modulates the plasticity and inhibits the motility of breast cancer cells role of notch1 and transforming growth factor (TGF β)

Journal of Biological Chemistry

Volumn 290, Issue 29, 2015, Pages 17690-17709

  Zanetti, Adriana ^a   Affatato, Roberta ^a   Centritto, Floriana ^a   Fratelli, Maddalena ^a   Kurosaki, Mami ^a   Barzago, Maria Monica ^a   Bolis, Marco ^a   Terao, Mineko ^a   Garattini, Enrico ^a   Paroni, Gabriela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITION;

ALL-TRANS RETINOIC ACIDS; BREAST CANCER; BREAST CANCER CELLS; EPITHELIAL TO MESENCHYMAL TRANSITIONS; MAMMARY TUMORS; THERAPEUTIC AGENTS; THERAPEUTIC LEVELS; TRANSFORMING GROWTH FACTORS;

DISEASES;

GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; HEREGULIN BETA1; N (N (3,5 DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE T BUTYL ESTER; NEU DIFFERENTIATION FACTOR; NOTCH1 RECEPTOR; RETINOIC ACID; RETINOID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CELL CONTACT; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GROWTH INHIBITION; INHIBITION KINETICS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; TIGHT JUNCTION; UPREGULATION; BREAST; BREAST NEOPLASMS; CELL MOTION; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; RECEPTOR, NOTCH1; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 84937389325     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.638510     Document Type: Article

References (61)

1. Garattini, E., Bolis, M., Garattini, S. K., Fratelli, M., Centritto, F., Paroni, G., Gianni', M., Zanetti, A., Pagani, A., Fisher, J. N., Zambelli, A., and Terao, M. (2014) Retinoids and breast cancer: from basic studies to the clinic and back again. Cancer Treat. Rev. 40, 739-749.
2. Rochette-Egly, C., and Germain, P. (2009) Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl. Recept. Signal. 7, e005.
3. Wang, Y. A., Shen, K., Wang, Y., and Brooks, S. C. (2005) Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev. Dyn. 234, 892-899.
4. Cho, K. W., Kwon, H. J., Shin, J. O., Lee, J. M., Cho, S. W., Tickle, C., and Jung, H. S. (2012) Retinoic acid signaling and the initiation of mammary gland development. Dev. Biol. 365, 259-266.
5. Niederreither, K., and Dollé, P. (2008) Retinoic acid in development: Towards an integrated view. Nat. Rev. Genet. 9, 541-553.
6. Paroni, G., Fratelli, M., Gardini, G., Bassano, C., Flora, M., Zanetti, A., Guarnaccia, V., Ubezio, P., Centritto, F., Terao, M., and Garattini, E. (2012) Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. Oncogene 31, 3431-3443.
7. Shah, S., Pishvaian, M. J., Easwaran, V., Brown, P. H., and Byers, S. W. (2002) The role of cadherin, β-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferation. J. Biol. Chem. 277, 25313-25322.
8. Nieto, M. A. (2013) Epithelial plasticity: A common theme in embryonic and cancer cells. Science 342, 1234850.
9. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
10. Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., Creasap, N., Rosol, T. J., Robinson, M. L., Eng, C., Ostrowski, M. C., and Leone, G. (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68, 937-945.
11. Micalizzi, D. S., Farabaugh, S. M., and Ford, H. L. (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 15, 117-134.
12. Brabletz, T. (2012) To differentiate or not: routes towards metastasis. Nat. Rev. Cancer 12, 425-436.
13. Guruharsha, K. G., Kankel, M. W., and Artavanis-Tsakonas, S. (2012) The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat. Rev. Genet. 13, 654-666.
14. Kopan, R., and Ilagan, M. X. (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233.
15. Leong, K. G., Niessen, K., Kulic, I., Raouf, A., Eaves, C., Pollet, I., and Karsan, A. (2007) Jagged1-mediated Notch activation induces epithelialto- mesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med. 204, 2935-2948.
16. Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., and Lendahl, U. (2008) Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U.S.A. 105, 6392-6397.
17. Zavadil, J., Cermak, L., Soto-Nieves, N., and Böttinger, E. P. (2004) Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-tomesenchymal transition. EMBO J. 23, 1155-1165.
18. Gianni, M., Zanotta, S., Terao, M., Garattini, S., and Garattini, E. (1993) Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells. Biochem. Biophys. Res. Commun. 196, 252-259.
19. Voigt, W. (2005) Sulforhodamine B assay and chemosensitivity. Methods Mol. Med. 110, 39-48.
20. Corada, M., Liao, F., Lindgren, M., Lampugnani, M. G., Breviario, F., Frank, R., Muller, W. A., Hicklin, D. J., Bohlen, P., and Dejana, E. (2001) Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97, 1679-1684.
21. Paroni, G., Henderson, C., Schneider, C., and Brancolini, C. (2001) Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3. J. Biol. Chem. 276, 21907-21915.
22. Vogelmann, R., Nguyen-Tat, M. D., Giehl, K., Adler, G., Wedlich, D., and Menke, A. (2005) TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN. J. Cell Sci. 118, 4901-4912.
23. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402-408.
24. Kao, J., Salari, K., Bocanegra, M., Choi, Y. L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P., Gazdar, A. F., Minna, J. D., and Pollack, J. R. (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4, e6146.
25. Lacroix, M., and Leclercq, G. (2004) Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res. Treat. 83, 249-289.
26. Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., and Thompson, E. W. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25, 629-642.
27. Hardy, K. M., Booth, B. W., Hendrix, M. J., Salomon, D. S., and Strizzi, L. (2010) ERBB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 15, 191-199.
28. Hugo, H. J., Wafai, R., Blick, T., Thompson, E. W., and Newgreen, D. F. (2009) Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction: A model for cross-modulation. BMC Cancer 9, 235.
29. Cheng, L., Zha, Z., Lang, B., Liu, J., and Yao, X. (2009) Heregulin-β1 promotes metastasis of breast cancer cell line SKBR3 through upregulation of Snail and induction of epithelial-mesenchymal transition. Cancer Lett. 280, 50-60.
30. Voura, E. B., Sandig, M., and Siu, C. H. (1998) Cell-cell interactions during transendothelial migration of tumor cells. Microsc. Res. Tech. 43, 265-275.
31. Wallez, Y., and Huber, P. (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim. Biophys. Acta 1778, 794-809.
32. Hollestelle, A., Peeters, J. K., Smid, M., Timmermans, M., Verhoog, L. C., Westenend, P. J., Heine, A. A., Chan, A., Sieuwerts, A. M., Wiemer, E. A., Klijn, J. G., van der Spek, P. J., Foekens, J. A., Schutte, M., den Bakker, M. A., and Martens, J. W. (2013) Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Res. Treat. 138, 47-57.
33. Debnath, J., and Brugge, J. S. (2005) Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688.
34. Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos-Hoff, M. H., Petersen, O. W., Gray, J. W., and Bissell, M. J. (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 1, 84-96.
35. Ocaña, O. H., Córcoles, R., Fabra, A., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., and Nieto, M. A. (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724.
36. Lo, H. W., Hsu, S. C., Xia, W., Cao, X., Shih, J. Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., and Hung, M. C. (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67, 9066-9076.
37. Friedl, P., Locker, J., Sahai, E., and Segall, J. E. (2012) Classifying collective cancer cell invasion. Nat. Cell Biol. 14, 777-783.
38. Nam, D. H., Jeon, H. M., Kim, S., Kim, M. H., Lee, Y. J., Lee, M. S., Kim, H., Joo, K. M., Lee, D. S., Price, J. E., Bang, S. I., and Park, W. Y. (2008) Activation of notch signaling in a xenograft model of brain metastasis. Clin. Cancer Res. 14, 4059-4066.
39. Parr, C., Watkins, G., and Jiang, W. G. (2004) The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int. J. Mol. Med. 14, 779-786.
40. Suman, S., Das, T. P., and Damodaran, C. (2013) Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. Br. J. Cancer 109, 2587-2596.
41. Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S., Fujita, M., and Kiyono, T. (2007) Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell Biol. 27, 3732-3742.
42. Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P., Rosato, A., Kaplan, F., Capobianco, A., Pece, S., Di Fiore, P. P., and Del Sal, G. (2009) The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 11, 133-142.
43. Schroeter, E. H., Kisslinger, J. A., and Kopan, R. (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-386.
44. Micchelli, C. A., Esler, W. P., Kimberly, W. T., Jack, C., Berezovska, O., Kornilova, A., Hyman, B. T., Perrimon, N., and Wolfe, M. S. (2003) γ-Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila. FASEB J. 17, 79-81.
45. Bolós, V., Mira, E., Martínez-Poveda, B., Luxán, G., Cañamero, M., Martínez-A, C., Mañes, S., and de la Pompa, J. L. (2013) Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res. 15, R54.
46. Wang, S. E., Xiang, B., Guix, M., Olivares, M. G., Parker, J., Chung, C. H., Pandiella, A., and Arteaga, C. L. (2008) Transforming growth factor βengages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol. Cell Biol. 28, 5605-5620.
47. Kretzschmar, M., Doody, J., Timokhina, I., and Massagué, J. (1999) A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13, 804-816.
48. Sekimoto, G., Matsuzaki, K., Yoshida, K., Mori, S., Murata, M., Seki, T., Matsui, H., Fujisawa, J., and Okazaki, K. (2007) Reversible Smad-depen-dent signaling between tumor suppression and oncogenesis. Cancer Res. 67, 5090-5096.
49. Robinson, D. R., Kalyana-Sundaram, S., Wu, Y. M., Shankar, S., Cao, X., Ateeq, B., Asangani, I. A., Iyer, M., Maher, C. A., Grasso, C. S., Lonigro, R. J., Quist, M., Siddiqui, J., Mehra, R., Jing, X., Giordano, T. J., Sabel, M. S., Kleer, C. G., Palanisamy, N., Natrajan, R., Lambros, M. B., Reis-Filho, J. S., Kumar-Sinha, C., and Chinnaiyan, A. M. (2011) Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646-1651.
50. Lo-Coco, F., Ammatuna, E., Montesinos, P., and Sanz, M. A. (2008) Acute promyelocytic leukemia: recent advances in diagnosis and management. Semin. Oncol. 35, 401-409.
51. Wolbach, S. B., and Howe, P. R. (1925) Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 42, 753-777.
52. Wolbach, S. B., and Howe, P. R. (1933) Epithelial repair in recovery from vitamin A deficiency: An experimental study. J. Exp. Med. 57, 511-526.
53. Friedl, P., and Alexander, S. (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009.
54. Doi, A., Ishikawa, K., Shibata, N., Ito, E., Fujimoto, J., Yamamoto, M., Shiga, H., Mochizuki, H., Kawamura, Y., Goshima, N., Semba, K., and Watanabe, S. (2015) Enhanced expression of retinoic acid receptorα (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures. Mol. Oncol. 9, 355-364.
55. Heldin, C. H., Vanlandewijck, M., and Moustakas, A. (2012) Regulation of EMT by TGFβ in cancer. FEBS Lett. 586, 1959-1970.
56. Zhang, C. C., Pavlicek, A., Zhang, Q., Lira, M. E., Painter, C. L., Yan, Z., Zheng, X., Lee, N. V., Ozeck, M., Qiu, M., Zong, Q., Lappin, P. B., Wong, A., Rejto, P. A., Smeal, T., and Christensen, J. G. (2012) Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models. Clin. Cancer Res. 18, 5008-5019.
57. Centritto, F., Paroni, G., Bolis, M., Garattini, S. K., Kurosaki, M., Barzago, M. M., Zanetti, A., Fisher, J. N., Scott, M. F., Pattini, L., Lupi, M., Ubezio, P., Piccotti, F., Zambelli, A., Rizzo, P., Gianni, M., Fratelli, M., Terao, M., and Garattini, E. (2015) Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RAR-α expression. EMBO Mol. Med. 10.15252/emmm.201404670.
58. Liu, H., Zang, C., Fenner, M. H., Possinger, K., and Elstner, E. (2003) PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res. Treat. 79, 63-74.
59. Wu, Q., Chen, Y. Q., Chen, Z. M., Chen, F., and Su, W. J. (2002) Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro. Acta Pharmacol. Sin. 23, 835-841.
60. Barroga, E. F., Kadosawa, T., Okumura, M., and Fujinaga, T. (2000) Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo. Res. Vet. Sci. 68, 79-87.
61. Shao, S., Zhao, X., Zhang, X., Luo, M., Zuo, X., Huang, S., Wang, Y., Gu, S., and Zhao, X. (2015) Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol. Cancer 14, 28.